Detalhe da pesquisa
1.
Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.
PLoS Med;
21(3): e1004360, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38502656
2.
Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines.
PLoS Med;
17(2): e1003038, 2020 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32092060
3.
Undue inducement: a case study in CAPRISA 008.
J Med Ethics;
43(12): 824-828, 2017 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28348164
4.
Challenges with participant reimbursement: experiences from a post-trial access study.
J Med Ethics;
41(11): 909-13, 2015 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26392172
5.
Disclosure of microbicide gel use to sexual partners: influence on adherence in the CAPRISA 004 trial.
AIDS Behav;
18(5): 849-54, 2014 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24633715
6.
Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials.
EBioMedicine;
64: 103203, 2021 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33493795
7.
Integrated provision of topical pre-exposure prophylaxis in routine family planning services in South Africa: a non-inferiority randomized controlled trial.
J Int AIDS Soc;
22(9): e25381, 2019 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31507088
8.
Using Mobile Technology (pMOTAR) to Assess Reactogenicity: Protocol for a Pilot Randomized Controlled Trial.
JMIR Res Protoc;
7(10): e175, 2018 Oct 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30282622
9.
Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial.
Lancet HIV;
5(7): e366-e378, 2018 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29898870
10.
Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men.
PLoS One;
10(9): e0137666, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26368824
11.
Assessing the implementation effectiveness and safety of 1% tenofovir gel provision through family planning services in KwaZulu-Natal, South Africa: study protocol for an open-label randomized controlled trial.
Trials;
15: 496, 2014 Dec 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25527071
12.
Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study.
Lancet Infect Dis;
14(5): 388-96, 2014 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24560541
13.
Adverse events with isoniazid preventive therapy: experience from a large trial.
AIDS;
24 Suppl 5: S29-36, 2010 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21079425
14.
'Team up against TB': promoting involvement in Thibela TB, a trial of community-wide tuberculosis preventive therapy.
AIDS;
24 Suppl 5: S37-44, 2010 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21079426